The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2023 / Oct / A Stunning Smear
Microscopy and imaging Training and education

A Stunning Smear

A look into a colourful cervical pap test

By Gloria Sura 10/04/2023 Gallery 2 min read
  • Full Article
  • Summary
  • Report

Share

Clinical Report: A Stunning Smear

Background

Low-grade squamous intraepithelial lesions (LSIL) are critical indicators of HPV-associated changes in cervical cytology. Understanding LSIL is essential for effective cervical cancer screening and management.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • LSIL reflects HPV-associated squamous changes, typically including koilocytosis.
  • Koilocytosis is characterized by perinuclear cavitation with irregular cytoplasmic borders in squamous cells.
  • In The Bethesda System, LSIL generally corresponds to histologic CIN 1.
  • Management of LSIL is guided by the ASCCP risk-based framework.
  • For patients younger than 25 years with LSIL, repeat cytology at 1 and 2 years is recommended.

Clinical Implications

Clinicians should be aware of the implications of LSIL findings in cervical cytology. Adhering to the ASCCP guidelines can optimize patient care.

Conclusion

The identification of LSIL in cervical cytology necessitates careful management based on established guidelines.

Related Resources & Content

  1. Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations - PMC
  2. Human Papillomavirus (HPV) Infection - STI Treatment Guidelines
  3. ASC-US/LSIL Triage Study (ALTS) - NCI
  4. the pathologist — The Picture of Health
  5. the pathologist — Birefringence
  6. the pathologist — The Art of the Laboratory
  7. the pathologist — Magical Microscopy
  8. Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations - PMC
  9. Human Papillomavirus (HPV) Infection - STI Treatment Guidelines
  10. ASC-US/LSIL Triage Study (ALTS) - NCI

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Gloria Sura

Cytomolecular Pathologist at MD Anderson Cancer Center, TX, USA.

More Articles by Gloria Sura

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.